| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |